Most powerful obesity drug yet: People lost up to 25% of weight in trial

September 29, 2026 · 10:01 pm 3 sources

Image: The Guardian

Coverage

Wires & papers of record

• ‘Godzilla’ of weight-loss drugs could provide other important health benefits
  The Guardian · September 29, 2026 22:01
  Though not yet approved by any regulatory agency, retatrutide could help improve blood sugar levels and reduce inflammation The ‘Godzilla’ of weight-loss drugs could help improve blood sugar levels, reduce inflammation and cut a person’s body weight by a quarter, according to the largest study of…

Coverage

• Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs
  Scientific American · September 29, 2026 22:01
  The experimental weight-loss drug is a triple agonist and the first of its kind to reach a phase 3 clinical trial
• Most powerful obesity drug yet: People lost up to 25% of weight in trial
  Ars Technica · September 29, 2026 22:30
  Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.